Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research

ALBANY, New York, February 20, 2013 /PRNewswire/ –

According to a new market report published by Transparency Market Research
(http://www.transparencymarketresearch.com), “Radiopharmaceuticals Market – Global
Industry Analysis, Size, Share, Trends and Forecast, 2012 – 2018,” the global market for
radiopharmaceuticals was valued at approximately USD 3.8 billion in 2011 and is expected
to reach USD 12.2 billion by 2018 at a CAGR of 18.3% from 2012 to 2018. North America led
the global radiopharmaceuticals market with the highest market share as Canada continues
to be the largest exporter of uranium and nuclear technology, forming the backbone of
nuclear medicine and imaging studies.

Browse the full report at

http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html

The market is expected to grow at a CAGR of 18.3% owing to tremendous research and
technological developments occurring worldwide and the increasing awareness about nuclear
medicine and molecular imaging procedures. The radiopharmaceuticals market is studied
based on end-user groups, medical isotopes, applications and geography. Technetium
(Tc-99m) is the most widely used radioisotope for medical applications. The majority of
the application market for radiopharmaceuticals is constituted by the diagnosis market,
and the therapeutic application segment is expected to grow at the fastest growth rate
from 2012 to 2018.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/healthcare-cloud-computing.html

http://www.transparencymarketresearch.com/hcro-market.html

http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html

http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

The global market for generators for radiopharmaceuticals was valued at over USD 200
million in 2011 and is expected to grow at a healthy CAGR from 2012 to 2018. The market
currently consists only of Tc-99m generators; newer generators for molecules like Rubidium
(Rb-82), Gallium (Ga-67) and Yttrium (Y-90) are expected to enter the market in the next
few years. These are expected to exhibit high double digit growth rates during the
forecast period.

Key players in this market include Covidien Plc, Nordion Inc., Lantheus Medical
Imaging and IBA Group, among others. The market is highly fragmented with leading global
healthcare companies offering a wide range of diagnostic and therapeutic
radiopharmaceuticals.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/insulin-market.html

http://www.transparencymarketresearch.com/us-vaccine-market.html

http://www.transparencymarketresearch.com/synthetic-biology-market.html

http://www.transparencymarketresearch.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market.html

http://www.transparencymarketresearch.com/asthma-and-copd-market.html

The study presents a comprehensive assessment of the stakeholder strategies, winning
imperatives for them by segmenting the radiopharmaceuticals market as below:

        - Radiopharmaceuticals Market by Generator Types
             - Mo-99/Tc-99m generator
             - Sr-82/Rb-82 generator
             - Ge-68/Ga-68 generator
             - Sr-90/Y-90 generator
             - W-188/Re-188 generator
        - Radiopharmaceuticals Market by End-Users
             - Hospitals & Medical Centers
             - Diagnostic Centers
        - Radiopharmaceuticals Market by Applications
             - Diagnosis
                - Diagnosis by Technique
                   - SPECT
                      - Technetium (Tc-99m)
                      - Thallium (TI-201)
                      - Gallium (Ga-67)
                      - Iodine (I-123)
                      - Rhenium (Re-186)
                      - Yttrium (Y-90)
                      - Others
                   - PET
                      - Fludeoxyglucose (18F-FDG)
                      - Rubidium (Rb-82)
                      - Others (Carbon-11 choline, Nitrogen-13 ammonia)
                - Diagnosis by Indications
                   - Oncology
                   - Cardiovascular
                   - Others (Neurological, Thyroid, Gastrointestinal)
             - Therapy
                - Systemic Oncology
                   - Iodine (I-131)
                   - Yttrium (90Y)
                   - Samarium (Sm-153)
                   - Strontium (89Sr)
                   - Rhenium (186Re)
                   - Lutetium (Lu-177)
                   - Erbium (169Er)
                   - Others
                - Others (Cardiology, Neurology)
        - Radiopharmaceuticals Market by Geography
             - North America
             - Europe
             - Asia-Pacific
             - Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Upcoming Reports in Pharmaceutical Market

Cell Based Assays Market
[http://www.transparencymarketresearch.com/cell-based-assays.html ]

Drug Discovery Technologies Market
[http://www.transparencymarketresearch.com/drug-discovery-technologies.html ]

Sample Preparation In Genomics
[http://www.transparencymarketresearch.com/sample-preparation.html ]

Antibody Drugs Market [http://www.transparencymarketresearch.com/antibody-drugs.html ]

Treatments for Neurodegenerative Disorders
[http://www.transparencymarketresearch.com/neurodegenerative-disorders.html ]

Polymerase Chain Reaction (PCR) Technologies
[http://www.transparencymarketresearch.com/pcr-technologies.html ]

Radiopharmaceuticals Market
[http://www.culrav.org/pr/global-radiopharmaceuticals-market-is-expected-to-reach-usd-12-2-billion-in-2018-transparency-market-research.php ]

Preventive Healthcare Technologies, Products & Services Market
[http://www.transparencymarketresearch.com/preventive-healthcare-technologies.html ]

Kinase Inhibitors Market
[http://www.transparencymarketresearch.com/kinase-inhibitors.html ]

Heparin Market [http://www.transparencymarketresearch.com/heparin-market.html ]

Theranostics Market
[http://www.transparencymarketresearch.com/theranostics-market.html ]

About Us

Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with a highly experienced team of Analysts, Researchers, and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information.

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business
reports.

Contact

        Sheela AK
        90 Sate Street, Suite 700
        Albany, NY 12207
        Tel: +1-518-618-1030
        USA - Canada Toll Free: +1-866-552-3453
        Email: sales@transparencymarketresearch.com
        Visit: http://de.transparencymarketresearch.com
        Visit: http://www.transparencymarketresearch.com

SOURCE Transparency Market Research